Abstract

The development of connectivity between the thalamus and maturing cortex is a fundamental process in the second half of human gestation, establishing the neural circuits that are the basis for several important brain functions. In this study, we acquired high-resolution in utero diffusion MRI from 140 fetuses as part of the Developing Human Connectome Project, to examine the emergence of thalamocortical white matter over the second to third trimester. We delineate developing thalamocortical pathways and parcellate the fetal thalamus according to its cortical connectivity using diffusion tractography. We then quantify microstructural tissue components along the tracts in fetal compartments that are critical substrates for white matter maturation, such as the subplate and intermediate zone. We identify patterns of change in the diffusion metrics that reflect critical neurobiological transitions occurring in the second to third trimester, such as the disassembly of radial glial scaffolding and the lamination of the cortical plate. These maturational trajectories of MR signal in transient fetal compartments provide a normative reference to complement histological knowledge, facilitating future studies to establish how developmental disruptions in these regions contribute to pathophysiology.

Data availability

Developing Human Connectome project data is open-access and available for download following completion of a data-usage agreement via: http://www.developingconnectome.org/. Data will also be available at: https://nda.nih.gov/edit_collection.html?id=3955

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Sian Wilson

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4617-3583
  2. Maximilian Pietsch

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Lucilio Cordero-Grande

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Daan Christiaens

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Alena Uus

    Department of Biomedical Engineering, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Vyacheslav R Karolis

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Vanessa Kyriakopoulou

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Kathleen Colford

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Anthony N Price

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Jana Hutter

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Mary A Rutherford

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Emer J Hughes

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Serena J Counsell

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8033-5673
  14. Jacques-Donald Tournier

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  15. Joseph V Hajnal

    Centre for the Developing Brain, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  16. A David Edwards

    Department of Biomedical Engineering, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4801-7066
  17. Jonathan O'Muicheartaigh

    Centre for the Developing Brain, King's College London, London, United Kingdom
    For correspondence
    jonathanom@kcl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  18. Tomoki Arichi

    Centre for the Developing Brain, King's College London, London, United Kingdom
    For correspondence
    tomoki.arichi@kcl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3550-1644

Funding

European Research Council (Seventh Framework Programme: FP/2007/2013)

  • Maximilian Pietsch
  • Lucilio Cordero-Grande
  • Daan Christiaens
  • Vyacheslav R Karolis
  • Vanessa Kyriakopoulou
  • Anthony N Price
  • Jana Hutter
  • Emer J Hughes
  • Jacques-Donald Tournier
  • Joseph V Hajnal
  • A David Edwards

Wellcome Trust (Sir Henry Dale Fellowship: 206675/Z/17/Z)

  • Jonathan O'Muicheartaigh

Medical Research Council Centre for Neurodevelopmental Disorders (MR/N0266063/1)

  • Sian Wilson
  • Mary A Rutherford
  • A David Edwards
  • Jonathan O'Muicheartaigh
  • Tomoki Arichi

Medical Research Council (Translation support fellowship: MR/V036874/1)

  • Vyacheslav R Karolis
  • Tomoki Arichi

Wellcome / EPSRC Centre for Biomedical Engineering, Kings College London (WT 203148/Z/16/Z)

  • Anthony N Price
  • Jana Hutter
  • Jacques-Donald Tournier
  • Joseph V Hajnal

Medical Research Council (Clinician Scientist Fellowship MR/P008712/1)

  • Tomoki Arichi

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Finnegan J Calabro, University of Pittsburgh, United States

Ethics

Human subjects: The study was approved by the UK Health Research Authority (Research Ethics Committee reference number: 14/LO/1169) and written parental consent was obtained in every case for imaging and open data release of the anonymized data.

Version history

  1. Received: September 26, 2022
  2. Preprint posted: October 25, 2022 (view preprint)
  3. Accepted: March 31, 2023
  4. Accepted Manuscript published: April 3, 2023 (version 1)
  5. Version of Record published: April 24, 2023 (version 2)
  6. Version of Record updated: May 26, 2023 (version 3)

Copyright

© 2023, Wilson et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,004
    views
  • 192
    downloads
  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sian Wilson
  2. Maximilian Pietsch
  3. Lucilio Cordero-Grande
  4. Daan Christiaens
  5. Alena Uus
  6. Vyacheslav R Karolis
  7. Vanessa Kyriakopoulou
  8. Kathleen Colford
  9. Anthony N Price
  10. Jana Hutter
  11. Mary A Rutherford
  12. Emer J Hughes
  13. Serena J Counsell
  14. Jacques-Donald Tournier
  15. Joseph V Hajnal
  16. A David Edwards
  17. Jonathan O'Muicheartaigh
  18. Tomoki Arichi
(2023)
Spatiotemporal tissue maturation of thalamocortical pathways in the human fetal brain
eLife 12:e83727.
https://doi.org/10.7554/eLife.83727

Share this article

https://doi.org/10.7554/eLife.83727

Further reading

    1. Developmental Biology
    Zhimin Xu, Zhao Wang ... Yingchuan B Qi
    Research Article

    Precise developmental timing control is essential for organism formation and function, but its mechanisms are unclear. In C. elegans, the microRNA lin-4 critically regulates developmental timing by post-transcriptionally downregulating the larval-stage-fate controller LIN-14. However, the mechanisms triggering the activation of lin-4 expression toward the end of the first larval stage remain unknown. We demonstrate that the transmembrane transcription factor MYRF-1 is necessary for lin-4 activation. MYRF-1 is initially localized on the cell membrane, and its increased cleavage and nuclear accumulation coincide with lin-4 expression timing. MYRF-1 regulates lin-4 expression cell-autonomously and hyperactive MYRF-1 can prematurely drive lin-4 expression in embryos and young first-stage larvae. The tandem lin-4 promoter DNA recruits MYRF-1GFP to form visible loci in the nucleus, suggesting that MYRF-1 directly binds to the lin-4 promoter. Our findings identify a crucial link in understanding developmental timing regulation and establish MYRF-1 as a key regulator of lin-4 expression.

    1. Developmental Biology
    2. Structural Biology and Molecular Biophysics
    Samuel C Griffiths, Jia Tan ... Hsin-Yi Henry Ho
    Research Article Updated

    The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.